Structure

Physi-Chem Properties

Molecular Weight:  284.07
Volume:  282.482
LogP:  4.116
LogD:  2.832
LogS:  -6.134
# Rotatable Bonds:  1
TPSA:  83.83
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.715
Synthetic Accessibility Score:  2.345
Fsp3:  0.125
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.075
MDCK Permeability:  1.517745931778336e-05
Pgp-inhibitor:  0.053
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.041
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.074
Plasma Protein Binding (PPB):  99.704345703125%
Volume Distribution (VD):  0.361
Pgp-substrate:  0.9842543005943298%

ADMET: Metabolism

CYP1A2-inhibitor:  0.951
CYP1A2-substrate:  0.839
CYP2C19-inhibitor:  0.156
CYP2C19-substrate:  0.068
CYP2C9-inhibitor:  0.63
CYP2C9-substrate:  0.555
CYP2D6-inhibitor:  0.254
CYP2D6-substrate:  0.256
CYP3A4-inhibitor:  0.597
CYP3A4-substrate:  0.177

ADMET: Excretion

Clearance (CL):  10.03
Half-life (T1/2):  0.089

ADMET: Toxicity

hERG Blockers:  0.02
Human Hepatotoxicity (H-HT):  0.042
Drug-inuced Liver Injury (DILI):  0.945
AMES Toxicity:  0.879
Rat Oral Acute Toxicity:  0.394
Maximum Recommended Daily Dose:  0.789
Skin Sensitization:  0.389
Carcinogencity:  0.904
Eye Corrosion:  0.005
Eye Irritation:  0.972
Respiratory Toxicity:  0.086

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC124365

Natural Product ID:  NPC124365
Common Name*:   Islandicin 4-Methyl Ether
IUPAC Name:   4,5-dihydroxy-1-methoxy-2-methylanthracene-9,10-dione
Synonyms:   Islandicin 4-Methyl Ether
Standard InCHIKey:  NNCFIAAUBKRACV-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H12O5/c1-7-6-10(18)12-13(16(7)21-2)14(19)8-4-3-5-9(17)11(8)15(12)20/h3-6,17-18H,1-2H3
SMILES:  COc1c(C)cc(c2c1C(=O)c1cccc(c1C2=O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL478711
PubChem CID:   11119613
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23982 Ventilago leiocarpa Species Rhamnaceae Eukaryota n.a. n.a. n.a. PMID[11374975]
NPO23982 Ventilago leiocarpa Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO23982 Ventilago leiocarpa Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO23982 Ventilago leiocarpa Species Rhamnaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1306 Cell Line WISH Homo sapiens IC50 > 100000.0 nM PMID[449623]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 > 100000.0 nM PMID[449623]
NPT80 Cell Line Raji Homo sapiens IC50 > 100000.0 nM PMID[449623]
NPT111 Cell Line K562 Homo sapiens IC50 > 100000.0 nM PMID[449623]
NPT165 Cell Line HeLa Homo sapiens IC50 > 100000.0 nM PMID[449623]
NPT1307 Cell Line Calu-1 Homo sapiens IC50 > 100000.0 nM PMID[449623]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC124365 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9704 High Similarity NPC1268
0.964 High Similarity NPC300540
0.9481 High Similarity NPC141934
0.9333 High Similarity NPC1249
0.9265 High Similarity NPC281513
0.9265 High Similarity NPC22222
0.9254 High Similarity NPC205992
0.9236 High Similarity NPC294646
0.9214 High Similarity NPC69755
0.9104 High Similarity NPC57552
0.9058 High Similarity NPC474813
0.9058 High Similarity NPC272268
0.903 High Similarity NPC282923
0.9028 High Similarity NPC56433
0.9028 High Similarity NPC118027
0.9028 High Similarity NPC289042
0.9028 High Similarity NPC126767
0.9028 High Similarity NPC245584
0.9028 High Similarity NPC190648
0.9028 High Similarity NPC312929
0.8993 High Similarity NPC245923
0.8973 High Similarity NPC147735
0.8973 High Similarity NPC290954
0.8973 High Similarity NPC255641
0.8951 High Similarity NPC274085
0.8951 High Similarity NPC89664
0.8912 High Similarity NPC473201
0.8912 High Similarity NPC302783
0.8905 High Similarity NPC70622
0.8889 High Similarity NPC478019
0.8881 High Similarity NPC96915
0.8881 High Similarity NPC476473
0.8881 High Similarity NPC53016
0.8874 High Similarity NPC284495
0.8857 High Similarity NPC305060
0.8844 High Similarity NPC470568
0.8841 High Similarity NPC115458
0.8836 High Similarity NPC5537
0.8824 High Similarity NPC99731
0.8819 High Similarity NPC193703
0.8819 High Similarity NPC19896
0.8819 High Similarity NPC21599
0.8819 High Similarity NPC477409
0.8816 High Similarity NPC311740
0.8815 High Similarity NPC45537
0.8811 High Similarity NPC474300
0.8806 High Similarity NPC103540
0.8792 High Similarity NPC208806
0.8792 High Similarity NPC477691
0.8792 High Similarity NPC135522
0.8786 High Similarity NPC155211
0.8784 High Similarity NPC470569
0.8776 High Similarity NPC70764
0.8767 High Similarity NPC478018
0.8767 High Similarity NPC71055
0.8759 High Similarity NPC136588
0.8759 High Similarity NPC199253
0.875 High Similarity NPC48248
0.875 High Similarity NPC476506
0.875 High Similarity NPC84571
0.8742 High Similarity NPC44199
0.8742 High Similarity NPC67197
0.8741 High Similarity NPC149780
0.8733 High Similarity NPC226656
0.8733 High Similarity NPC66508
0.8732 High Similarity NPC26924
0.8731 High Similarity NPC173978
0.8731 High Similarity NPC142956
0.8725 High Similarity NPC477690
0.8725 High Similarity NPC154683
0.8725 High Similarity NPC40356
0.8725 High Similarity NPC281272
0.8714 High Similarity NPC283088
0.8699 High Similarity NPC211565
0.8699 High Similarity NPC147250
0.8699 High Similarity NPC60389
0.8696 High Similarity NPC205360
0.8696 High Similarity NPC141549
0.869 High Similarity NPC48762
0.8686 High Similarity NPC146647
0.8686 High Similarity NPC34414
0.8684 High Similarity NPC324736
0.8681 High Similarity NPC329493
0.8671 High Similarity NPC315578
0.8667 High Similarity NPC107109
0.8658 High Similarity NPC118427
0.8658 High Similarity NPC39819
0.8657 High Similarity NPC375356
0.8649 High Similarity NPC329933
0.8645 High Similarity NPC26386
0.8643 High Similarity NPC288089
0.8639 High Similarity NPC119767
0.8639 High Similarity NPC34802
0.8633 High Similarity NPC474340
0.8633 High Similarity NPC246693
0.8633 High Similarity NPC110609
0.8633 High Similarity NPC58685
0.8633 High Similarity NPC242358
0.863 High Similarity NPC49282
0.863 High Similarity NPC34482
0.863 High Similarity NPC73416
0.863 High Similarity NPC160777
0.8623 High Similarity NPC278787
0.8623 High Similarity NPC7569
0.8623 High Similarity NPC55949
0.8621 High Similarity NPC167663
0.8621 High Similarity NPC66593
0.8618 High Similarity NPC178976
0.8611 High Similarity NPC145673
0.8609 High Similarity NPC66029
0.8609 High Similarity NPC3898
0.8603 High Similarity NPC306765
0.8603 High Similarity NPC3224
0.8601 High Similarity NPC471602
0.8601 High Similarity NPC256463
0.8601 High Similarity NPC29771
0.8601 High Similarity NPC477408
0.8601 High Similarity NPC470407
0.8601 High Similarity NPC306835
0.8601 High Similarity NPC111422
0.8601 High Similarity NPC143438
0.8601 High Similarity NPC476477
0.8601 High Similarity NPC216312
0.8601 High Similarity NPC299405
0.86 High Similarity NPC164912
0.86 High Similarity NPC3744
0.86 High Similarity NPC175978
0.8591 High Similarity NPC227122
0.8582 High Similarity NPC300274
0.8581 High Similarity NPC2569
0.8581 High Similarity NPC172329
0.8581 High Similarity NPC101769
0.8571 High Similarity NPC314048
0.8571 High Similarity NPC470570
0.8571 High Similarity NPC225051
0.8571 High Similarity NPC52407
0.8562 High Similarity NPC186113
0.8553 High Similarity NPC279605
0.8553 High Similarity NPC5379
0.8553 High Similarity NPC14561
0.8553 High Similarity NPC77807
0.8552 High Similarity NPC49108
0.8552 High Similarity NPC182255
0.8552 High Similarity NPC94076
0.8551 High Similarity NPC206028
0.8551 High Similarity NPC278928
0.8543 High Similarity NPC214632
0.8543 High Similarity NPC290927
0.8542 High Similarity NPC37992
0.8542 High Similarity NPC147542
0.8542 High Similarity NPC42262
0.8542 High Similarity NPC327916
0.8542 High Similarity NPC220496
0.8542 High Similarity NPC32749
0.8542 High Similarity NPC241349
0.854 High Similarity NPC470841
0.8535 High Similarity NPC234331
0.8533 High Similarity NPC144283
0.8531 High Similarity NPC13715
0.8531 High Similarity NPC475104
0.8523 High Similarity NPC80370
0.8523 High Similarity NPC266499
0.8519 High Similarity NPC182646
0.8516 High Similarity NPC146837
0.8516 High Similarity NPC278329
0.8511 High Similarity NPC274876
0.8506 High Similarity NPC470342
0.8506 High Similarity NPC472060
0.8506 High Similarity NPC472052
0.8503 High Similarity NPC471683
0.85 High Similarity NPC118253
0.85 High Similarity NPC309430
0.8497 Intermediate Similarity NPC37543
0.8497 Intermediate Similarity NPC263483
0.8497 Intermediate Similarity NPC199463
0.8493 Intermediate Similarity NPC84266
0.8493 Intermediate Similarity NPC163948
0.8489 Intermediate Similarity NPC198305
0.8489 Intermediate Similarity NPC475741
0.8489 Intermediate Similarity NPC31799
0.8483 Intermediate Similarity NPC257003
0.8483 Intermediate Similarity NPC187843
0.8483 Intermediate Similarity NPC283292
0.8483 Intermediate Similarity NPC471444
0.8477 Intermediate Similarity NPC137125
0.8477 Intermediate Similarity NPC149889
0.8477 Intermediate Similarity NPC312338
0.8472 Intermediate Similarity NPC18457
0.8472 Intermediate Similarity NPC223336
0.8472 Intermediate Similarity NPC242994
0.8472 Intermediate Similarity NPC138099
0.8471 Intermediate Similarity NPC29160
0.8467 Intermediate Similarity NPC205766
0.8467 Intermediate Similarity NPC315520
0.8467 Intermediate Similarity NPC202595
0.8462 Intermediate Similarity NPC471905
0.8462 Intermediate Similarity NPC53206
0.8462 Intermediate Similarity NPC476505
0.8462 Intermediate Similarity NPC53414
0.8456 Intermediate Similarity NPC186397

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC124365 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8904 High Similarity NPD3226 Approved
0.8806 High Similarity NPD1470 Approved
0.8794 High Similarity NPD2346 Discontinued
0.8592 High Similarity NPD2935 Discontinued
0.8507 High Similarity NPD1201 Approved
0.8392 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.828 Intermediate Similarity NPD6232 Discontinued
0.8239 Intermediate Similarity NPD7473 Discontinued
0.8227 Intermediate Similarity NPD2313 Discontinued
0.8125 Intermediate Similarity NPD1607 Approved
0.8071 Intermediate Similarity NPD2798 Approved
0.8014 Intermediate Similarity NPD1510 Phase 2
0.8014 Intermediate Similarity NPD2799 Discontinued
0.8013 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD7003 Approved
0.7987 Intermediate Similarity NPD6959 Discontinued
0.7986 Intermediate Similarity NPD1240 Approved
0.7959 Intermediate Similarity NPD5408 Approved
0.7959 Intermediate Similarity NPD5404 Approved
0.7959 Intermediate Similarity NPD5405 Approved
0.7959 Intermediate Similarity NPD5406 Approved
0.7949 Intermediate Similarity NPD7819 Suspended
0.7926 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD2344 Approved
0.7895 Intermediate Similarity NPD2532 Approved
0.7895 Intermediate Similarity NPD2533 Approved
0.7895 Intermediate Similarity NPD2534 Approved
0.7882 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD2801 Approved
0.7834 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD7390 Discontinued
0.7806 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD1283 Approved
0.78 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD8313 Approved
0.7784 Intermediate Similarity NPD8312 Approved
0.7778 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD4380 Phase 2
0.7754 Intermediate Similarity NPD1651 Approved
0.7748 Intermediate Similarity NPD3750 Approved
0.7748 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD1549 Phase 2
0.7724 Intermediate Similarity NPD3764 Approved
0.7718 Intermediate Similarity NPD1551 Phase 2
0.7714 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD5844 Phase 1
0.7697 Intermediate Similarity NPD2309 Approved
0.7676 Intermediate Similarity NPD1876 Approved
0.7673 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD1471 Phase 3
0.7667 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1934 Approved
0.7625 Intermediate Similarity NPD7768 Phase 2
0.7622 Intermediate Similarity NPD1203 Approved
0.7597 Intermediate Similarity NPD1511 Approved
0.7595 Intermediate Similarity NPD7411 Suspended
0.7593 Intermediate Similarity NPD5494 Approved
0.7589 Intermediate Similarity NPD1281 Approved
0.758 Intermediate Similarity NPD7458 Discontinued
0.7578 Intermediate Similarity NPD3749 Approved
0.7571 Intermediate Similarity NPD6782 Approved
0.7571 Intermediate Similarity NPD6779 Approved
0.7571 Intermediate Similarity NPD6778 Approved
0.7571 Intermediate Similarity NPD4626 Approved
0.7571 Intermediate Similarity NPD6776 Approved
0.7571 Intermediate Similarity NPD6781 Approved
0.7571 Intermediate Similarity NPD6777 Approved
0.7571 Intermediate Similarity NPD6780 Approved
0.7562 Intermediate Similarity NPD5402 Approved
0.7547 Intermediate Similarity NPD6844 Discontinued
0.7535 Intermediate Similarity NPD3972 Approved
0.7533 Intermediate Similarity NPD4308 Phase 3
0.75 Intermediate Similarity NPD1512 Approved
0.7483 Intermediate Similarity NPD2796 Approved
0.7483 Intermediate Similarity NPD411 Approved
0.7469 Intermediate Similarity NPD7075 Discontinued
0.7465 Intermediate Similarity NPD1611 Approved
0.7456 Intermediate Similarity NPD6559 Discontinued
0.7451 Intermediate Similarity NPD2800 Approved
0.745 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD447 Suspended
0.7444 Intermediate Similarity NPD7696 Phase 3
0.7444 Intermediate Similarity NPD7435 Discontinued
0.7444 Intermediate Similarity NPD7697 Approved
0.7444 Intermediate Similarity NPD7698 Approved
0.7442 Intermediate Similarity NPD8150 Discontinued
0.7425 Intermediate Similarity NPD7177 Discontinued
0.7419 Intermediate Similarity NPD3300 Phase 2
0.7417 Intermediate Similarity NPD3748 Approved
0.7415 Intermediate Similarity NPD4625 Phase 3
0.7413 Intermediate Similarity NPD9717 Approved
0.741 Intermediate Similarity NPD9493 Approved
0.741 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD3882 Suspended
0.7403 Intermediate Similarity NPD7871 Phase 2
0.7403 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4628 Phase 3
0.7403 Intermediate Similarity NPD7870 Phase 2
0.7391 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6273 Approved
0.7389 Intermediate Similarity NPD6823 Phase 2
0.7383 Intermediate Similarity NPD943 Approved
0.7383 Intermediate Similarity NPD2979 Phase 3
0.7368 Intermediate Similarity NPD6099 Approved
0.7368 Intermediate Similarity NPD6100 Approved
0.7365 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD6832 Phase 2
0.7312 Intermediate Similarity NPD6599 Discontinued
0.731 Intermediate Similarity NPD6696 Suspended
0.7305 Intermediate Similarity NPD6166 Phase 2
0.7305 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD1608 Approved
0.7289 Intermediate Similarity NPD5710 Approved
0.7289 Intermediate Similarity NPD5711 Approved
0.7288 Intermediate Similarity NPD6535 Approved
0.7288 Intermediate Similarity NPD6534 Approved
0.7283 Intermediate Similarity NPD7701 Phase 2
0.7267 Intermediate Similarity NPD4307 Phase 2
0.726 Intermediate Similarity NPD2797 Approved
0.726 Intermediate Similarity NPD1164 Approved
0.7256 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD5691 Approved
0.7248 Intermediate Similarity NPD3268 Approved
0.7246 Intermediate Similarity NPD7635 Approved
0.7232 Intermediate Similarity NPD6212 Phase 3
0.7232 Intermediate Similarity NPD6213 Phase 3
0.7232 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6801 Discontinued
0.7219 Intermediate Similarity NPD3751 Discontinued
0.7219 Intermediate Similarity NPD3818 Discontinued
0.7215 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD7874 Approved
0.7203 Intermediate Similarity NPD3019 Approved
0.7195 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD6651 Approved
0.7167 Intermediate Similarity NPD7699 Phase 2
0.7167 Intermediate Similarity NPD7700 Phase 2
0.7166 Intermediate Similarity NPD7801 Approved
0.7162 Intermediate Similarity NPD2861 Phase 2
0.7152 Intermediate Similarity NPD6799 Approved
0.7152 Intermediate Similarity NPD4060 Phase 1
0.7143 Intermediate Similarity NPD5951 Approved
0.7134 Intermediate Similarity NPD2296 Approved
0.7134 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD3817 Phase 2
0.7132 Intermediate Similarity NPD2342 Discontinued
0.7126 Intermediate Similarity NPD1247 Approved
0.7125 Intermediate Similarity NPD920 Approved
0.7125 Intermediate Similarity NPD5403 Approved
0.7123 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD37 Approved
0.7107 Intermediate Similarity NPD5401 Approved
0.7105 Intermediate Similarity NPD1933 Approved
0.7093 Intermediate Similarity NPD5953 Discontinued
0.7092 Intermediate Similarity NPD6671 Approved
0.7083 Intermediate Similarity NPD17 Approved
0.7083 Intermediate Similarity NPD2932 Approved
0.7083 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD1465 Phase 2
0.7071 Intermediate Similarity NPD1398 Phase 1
0.7067 Intermediate Similarity NPD7008 Discontinued
0.7055 Intermediate Similarity NPD1481 Phase 2
0.7047 Intermediate Similarity NPD9494 Approved
0.7045 Intermediate Similarity NPD8434 Phase 2
0.7044 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD7340 Approved
0.7035 Intermediate Similarity NPD7074 Phase 3
0.7034 Intermediate Similarity NPD3496 Discontinued
0.7032 Intermediate Similarity NPD2531 Phase 2
0.7032 Intermediate Similarity NPD4477 Approved
0.7032 Intermediate Similarity NPD4476 Approved
0.7032 Intermediate Similarity NPD2438 Suspended
0.7027 Intermediate Similarity NPD3267 Approved
0.7027 Intermediate Similarity NPD3266 Approved
0.7025 Intermediate Similarity NPD3295 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD1243 Approved
0.7006 Intermediate Similarity NPD6234 Discontinued
0.7006 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.6989 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4967 Phase 2
0.6988 Remote Similarity NPD4966 Approved
0.6988 Remote Similarity NPD4965 Approved
0.6986 Remote Similarity NPD1535 Discovery
0.698 Remote Similarity NPD1019 Discontinued
0.6977 Remote Similarity NPD7054 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data